Legal consultation is being pursued through India Brand Equity Foundation and preliminary opinion of our legal counsel has advised us to do...

The US drug regulator says it has detected no impurity in the Indian version of cholesterol-lowering generic drug Atorvastatin in recent te...

This latest set of data from the government comes amidst doubts raised by a section of American doctors and academicians over the quality o...

“My case against Ranbaxy and what happened with Heparin in China show unscrupulous actors in global supply chain take advantage of gaps in ...